Latin America Infusion Pump Market by Product (Accessories & Consumables, Devices (Volumetric, Insulin, Syringe, Ambulatory, PCA)), Application (Chemotherapy, Diabetes, Analgesia, Pediatrics, Hematology), End User (Hospitals) - Global Forecast to 2030
상품코드:1819092
리서치사:MarketsandMarkets
발행일:2025년 09월
페이지 정보:영문 297 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
라틴아메리카의 주입 펌프 시장 규모는 2025년 7억 4,000만 달러에서 2030년까지 10억 달러에 달할 것으로 예측되며, 예측 기간에 CAGR로 6.2%의 성장이 전망됩니다.
조사 범위
조사 대상 연도
2024-2030년
기준 연도
2024년
예측 기간
2025-2030년
단위
10억 달러
부문
제품, 용도, 최종사용자
대상 지역
브라질, 멕시코, 아르헨티나, 콜롬비아, 칠레, 에콰도르, 페루, 기타 라틴아메리카
라틴아메리카의 주입 펌프 시장은 만성질환 증가, 인구통계학적 변화, 의료시설 확충 등의 요인에 힘입어 꾸준히 성장하고 있습니다. 이 지역에서는 당뇨병, 암, 심혈관질환 등의 질병이 흔하게 발생하고 있으며, 많은 경우 정확하고 지속적인 약물전달이 요구됩니다. 주입 펌프는 특히 장기 치료가 필요한 환자에게 의사가 정확한 치료를 제공하는 데 도움을 주고 있습니다. 또한, 노인 인구의 증가도 이러한 수요에 기여하고 있습니다. 노인들은 보통 약물을 자주, 그리고 조절하면서 투여해야 하기 때문입니다. 이와 더불어, 종양 치료 및 응급 처치에 대한 수요가 증가함에 따라 주입 펌프는 라틴아메리카 전역의 병원과 클리닉에 필수적인 장비가 되었습니다.
제품별로는 액세서리 및 소모품 부문이 2024년 가장 큰 시장 점유율을 차지했습니다.
액세서리 및 소모품 부문은 주입 펌프의 가동률 증가와 수액 세트, 카테터, 튜브와 같은 소모품에 대한 정기적인 수요 증가에 힘입어 성장세를 보이고 있습니다. 장기 치료 및 입원의 증가도 정기적인 교체 및 유지보수 부품에 대한 수요를 증가시키고 있습니다.
제품(장치)별로는 용적식 주입 펌프 부문이 2024년 가장 큰 시장 점유율을 차지했습니다.
라틴아메리카 시장에서의 체적식 주입 펌프 부문의 성장은 정확한 수액 투여가 필요한 만성질환의 유병률 증가와 지역 내 의료 인프라의 확대에 기인합니다. 또한, 안전 기능이 강화된 스마트 펌프를 포함한 첨단 수액 기술의 채택과 의료비 증가가 이 부문의 확대에 기여하고 있습니다.
용도별로는 당뇨병 부문이 2024년 가장 큰 시장 점유율을 차지했습니다.
당뇨병 유병률의 증가와 정확하고 지속적인 인슐린 투여를 위한 인슐린 펌프의 채택이 증가함에 따라 당뇨병 부문이 가장 큰 시장 점유율을 차지했습니다. 선진화된 당뇨병 관리에 대한 인식이 높아지면서 의료 지원 노력이 수요를 더욱 가속화하고 있습니다.
2024년 브라질은 거대한 환자 인구와 만성질환의 높은 유병률로 인해 주요 병원 시스템에서 종양, 당뇨병, 응급처치 및 수액 요법에 대한 수요를 촉진하여 가장 큰 시장 점유율을 차지했습니다. 병원 인프라와 IT의 발전에 힘입어 스마트 펌프와 이동식 펌프의 사용이 증가하고 있으며, 채택과 교체 속도가 빨라지고 있습니다. 또한, 정부와 민간의 의료 투자와 브라질의 보조 의료 시스템 확대로 인해 조달 능력이 강화되고, 전사적 수액 플랫폼과 서비스 계약을 촉진하는 표준화 활동이 지원되고 있습니다.
라틴아메리카의 주입 펌프 시장에 대해 조사 분석했으며, 주요 촉진요인과 억제요인, 경쟁 상황, 향후 동향 등의 정보를 전해드립니다.
The Latin America infusion pumps market is projected to reach USD 1.00 billion by 2030 from USD 0.74 billion in 2025, at a CAGR of 6.2% during the forecast period.
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2024
Forecast Period
2025-2030
Units Considered
Value (USD billion)
Segments
By Product, Application, and End User
Regions covered
Brazil, Mexico, Argentina, Colombia, Chile, Ecuador, Peru, and the rest of Latin America
The infusion pumps market in Latin America is growing steadily, supported by factors such as rising chronic diseases, changing demographics, and better healthcare facilities. Conditions like diabetes, cancer, and cardiovascular disorders are becoming more common in the region and often require precise and continuous delivery of medicines. Infusion pumps help doctors provide accurate treatment, especially for patients who need long-term care. The growing elderly population also adds to this demand, as older people usually need frequent and controlled drug administration. Along with this, the increasing need for oncology and critical care therapies makes infusion pumps essential for hospitals and clinics across Latin America.
By product, the accessories & consumables segment accounted for the largest share of the market in 2024.
By product, the Latin America infusion pumps market has been segmented into accessories & consumables and devices. The accessories & consumables segment accounted for the largest share of the infusion pumps market in 2024. The accessories & consumables segment is driven by the growing installed base of infusion pumps and the recurring need for disposables like IV sets, catheters, and tubing. The rise in long-term therapies and hospital admissions also increases demand for regular replacement and maintenance components.
By product (devices), the volumetric infusion pumps segment accounted for the largest market share in 2024.
Based on devices, the Latin America infusion pumps market is segmented into volumetric infusion pumps, insulin pumps, enteral infusion pumps, ambulatory infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) pumps, and implantable infusion pumps. The volumetric infusion pumps segment accounted for the largest infusion pump devices market share in 2024. The growth of the volumetric infusion pumps segment in the LATAM market is driven by the rising prevalence of chronic diseases necessitating precise fluid administration and the expansion of healthcare infrastructure across the region. Additionally, adopting advanced infusion technologies, including smart pumps with enhanced safety features, and increased healthcare spending contribute to the segment's expansion.
By application, the diabetes segment accounted for the largest share of the market in 2024.
Based on application, the Latin America infusion pumps market is segmented into chemotherapy/oncology, diabetes management, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver). The diabetes segment accounted for the largest market share owing to the rising prevalence of diabetes and the increasing adoption of insulin pumps for precise, continuous insulin delivery. Growing awareness of advanced diabetes management and supportive healthcare initiatives further accelerates demand.
By country, Brazil accounted for the largest share of the market in 2024.
The Latin America infusion pump market is divided by country, including Brazil, Mexico, Argentina, Colombia, Chile, Ecuador, Peru, and the Rest of Latin America. In 2024, Brazil accounted for the largest market share, driven by its large patient population and high prevalence of chronic diseases, fueling the demand for infusion therapies in oncology, diabetes, and critical care across leading hospital systems. The growing use of smart and ambulatory pumps, aided by advancements in hospital infrastructure and IT, accelerates adoption and replacement rates. Additionally, government and private healthcare investments and Brazil's expansive supplementary health plans are enhancing procurement capacity and supporting standardization efforts that promote enterprise-wide infusion platforms and service agreements.
A breakdown of the primary participants (supply-side) for the Latin America infusion pumps market referred to in this report is provided below:
By Company Type: Tier 1-45%, Tier 2-20%, and Tier 3-35%
By Designation: C-level-35%, Director Level-25%, and Others-40%
By Region: Brazil-40%, Mexico-25%, Argentina-20%, Colombia- 10%, and the Rest of Latin America- 5%.
The key players in the Latin America infusion pumps market include are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), Medtronic plc (Ireland), ICU Medical, Inc. (US), Terumo Corporation (Japan), Nipro Corporation (Japan), Avanos Medical, Inc. (US), JMS Co., Ltd. (Japan), Cardinal Health, Inc. (US), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Ypsomed Holding AG (Switzerland), and Tandem Diabetes Care, Inc. (US), Harvard Bioscience, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Intuvie Holding LLC (US), among others.
Research Coverage:
The report analyzes the Latin America infusion pumps market and estimates the market size and future growth potential based on various segments such as devices & consumables, cancer type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall Latin America infusion pumps market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (rising incidence of diabetes, growing geriatric population and subsequent rise in chronic diseases, rising number of surgical procedures, and the increasing adoption of enteral feeding pumps due to surge in pre-term births), restraints (stringent regulatory requirements for product commercialization, increasing adoption of refurbished & rented infusion pumps), opportunities (high growth potential in emerging economies and the increasing adoption of specialty infusion systems), challenges (increasing incidence of medication errors and inadequate wireless connectivity across several hospitals)
Market Penetration: Comprehensive information on product portfolios offered by the top players in the Latin America infusion pumps market. The report analyzes this market by product, application, and end user.
Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the Latin America infusion pumps market
Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user.
Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the Latin America infusion pumps market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the Latin America infusion pumps market.
